T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
KeyCorp
KEY
$24.6B
| $20M | ﹤0.01% |
1,262,369
-56,382
| -4% | -$814K |
|
977
Virtus Investment Partners
VRTS
$1.14B
| $19.9M | ﹤0.01% |
80,242
-1,613
| -2% | -$382K |
|
978
LKQ Corp
LKQ
$6.38B
| $19.7M | ﹤0.01% |
369,526
-12,282
| -3% | -$609K |
|
979
McGrath RentCorp
MGRC
$2.94B
| $19.7M | ﹤0.01% |
159,946
-115,547
| -42% | -$14M |
|
|
CPRX
980
DELISTED
Catalyst Pharmaceutical
CPRX
| $19.4M | ﹤0.01% |
1,219,418
+22,860
| +2% | +$344K |
|
981
iShares Core MSCI EAFE ETF
IEFA
$196B
| $19.3M | ﹤0.01% |
259,667
+47,567
| +22% | +$3.39M |
|
982
Travel + Leisure Co
TNL
$4.58B
| $19.2M | ﹤0.01% |
392,299
+7,392
| +2% | +$316K |
|
983
CarMax
KMX
$8.52B
| $19M | ﹤0.01% |
217,647
+5,011
| +2% | +$379K |
|
984
Freshworks
FRSH
$3.51B
| $18.8M | ﹤0.01% |
1,031,053
-1,642,580
| -61% | -$34M |
|
985
Tencent Music
TME
$14.2B
| $18.7M | ﹤0.01% |
1,675,273
-140,120
| -8% | -$1.37M |
|
986
Allogene Therapeutics
ALLO
$683M
| $18.7M | ﹤0.01% |
4,177,619
+1,806,147
| +76% | +$7.54M |
|
987
PTC Therapeutics
PTCT
$6.01B
| $18.6M | ﹤0.01% |
639,867
-358,436
| -36% | -$10M |
|
988
Pentair
PNR
$10.7B
| $18.6M | ﹤0.01% |
217,771
+432
| +0.2% | +$32.7K |
|
989
APA Corp
APA
$14B
| $18.3M | ﹤0.01% |
532,671
-355,671
| -40% | -$11.3M |
|
990
J.M. Smucker
SJM
$12.9B
| $18.3M | ﹤0.01% |
145,306
+1,239
| +0.9% | +$157K |
|
|
RAPT
991
DELISTED
RAPT Therapeutics
RAPT
| $18.2M | ﹤0.01% |
253,521
-173,173
| -41% | -$24.1M |
|
992
Flywire
FLYW
$2.22B
| $18.2M | ﹤0.01% |
731,587
-212,716
| -23% | -$4.97M |
|
993
SEACOR Marine Holdings
SMHI
$262M
| $18.1M | ﹤0.01% |
1,298,123
-2,728,985
| -68% | -$31.6M |
|
|
NARI
994
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $17.9M | ﹤0.01% |
373,347
+2,003
| +0.5% | +$107K |
|
995
Healthpeak Properties
DOC
$14.3B
| $17.9M | ﹤0.01% |
952,432
+220,137
| +30% | +$4M |
|
996
Palomar
PLMR
$3.37B
| $17.8M | ﹤0.01% |
212,588
-6,480
| -3% | -$444K |
|
997
American Financial Group
AFG
$12.1B
| $17.8M | ﹤0.01% |
130,537
-21,184
| -14% | -$2.64M |
|
998
SLM Corp
SLM
$5.22B
| $17.8M | ﹤0.01% |
816,274
+26,064
| +3% | +$520K |
|
999
Revvity
RVTY
$13.1B
| $17.7M | ﹤0.01% |
168,547
+2,153
| +1% | +$229K |
|
|
IPG
1000
DELISTED
Interpublic Group of Companies
IPG
| $17.7M | ﹤0.01% |
542,230
-396,835
| -42% | -$12.9M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.